Clarification sought from Sanofi India

29 Mar 2017 Evaluate

The Exchange has sought clarification from Sanofi India on March 29, 2017, with reference to the news flashed on www.reuters.com dated March 29, 2017 quoting ‘FDA Approves Regeneron, Sanofi $37,000 per year eczema drug’.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

4070.10 -15.50 (-0.38%)
30-Dec-2025 10:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.20
Dr. Reddys Lab 1270.50
Cipla 1487.20
Zydus Lifesciences 899.25
Lupin 2082.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×